Data Integrity Questions Cast Pall On Alzheimer’s Agitation Data For BioXcel’s Igalmi

The company reported positive efficacy results, but also revealed allegations that an investigator had failed to adhere to trial protocol and was alleged to have fabricated emails to cover their tracks.